Skip to content

Clinical trials

Neoplasm Recurrence, Local trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Recurrence, Local Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20151
20171
20181
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Institute and Hospital, Chinese Academy of Medical Sciences2
Shandong Cancer Hospital and Institute2
Beijing Chao Yang Hospital1
Fujian Medical University Union Hospital1
Peking University First Hospital1
Sixth Affiliated Hospital, Sun Yat-sen University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Recurrence, Local8
Neoplasm Metastasis3
Breast Neoplasms2
Neoplasms2
Agnosia1
Colorectal Neoplasms1
Endometrial Neoplasms1
Lung Neoplasms1
Postoperative Complications1
Rectal Neoplasms1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.